Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Chemically induced neurite-like outgrowth reveals a multicellular network function in patient-derived glioblastoma cells.

da Silva B, Irving BK, Polson ES, Droop A, Griffiths HBS, Mathew RK, Stead LF, Marrison J, Williams C, Williams J, Short SC, Scarcia M, O'Toole PJ, Allison SJ, Mavria G, Wurdak H.

J Cell Sci. 2019 Oct 10;132(19). pii: jcs228452. doi: 10.1242/jcs.228452.

PMID:
31515278
2.

Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.

Liakouli V, Cipriani P, Di Benedetto P, Panzera N, Ruscitti P, Pantano I, Berardicurti O, Carubbi F, Esteves F, Mavria G, Del Galdo F, Giacomelli R.

Sci Rep. 2019 Mar 14;9(1):4589. doi: 10.1038/s41598-019-39485-8.

3.

Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.

Westbrook JA, Wood SL, Cairns DA, McMahon K, Gahlaut R, Thygesen H, Shires M, Roberts S, Marshall H, Oliva MR, Dunning MJ, Hanby AM, Selby PJ, Speirs V, Mavria G, Coleman RE, Brown JE.

J Pathol. 2019 Mar;247(3):381-391. doi: 10.1002/path.5197. Epub 2019 Jan 25.

4.

Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.

Liakouli V, Elies J, El-Sherbiny YM, Scarcia M, Grant G, Abignano G, Derrett-Smith EC, Esteves F, Cipriani P, Emery P, Denton CP, Giacomelli R, Mavria G, Del Galdo F.

Ann Rheum Dis. 2018 Mar;77(3):431-440. doi: 10.1136/annrheumdis-2017-212120. Epub 2017 Dec 19.

5.

Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain.

DiCara DM, Chirgadze DY, Pope AR, Karatt-Vellatt A, Winter A, Slavny P, van den Heuvel J, Parthiban K, Holland J, Packman LC, Mavria G, Hoffmann J, Birchmeier W, Gherardi E, McCafferty J.

Sci Rep. 2017 Aug 21;7(1):9000. doi: 10.1038/s41598-017-09460-2.

6.

A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis.

Abraham S, Scarcia M, Bagshaw RD, McMahon K, Grant G, Harvey T, Yeo M, Esteves FOG, Thygesen HH, Jones PF, Speirs V, Hanby AM, Selby PJ, Lorger M, Dear TN, Pawson T, Marshall CJ, Mavria G.

Nat Commun. 2015 Jul 1;6:7286. doi: 10.1038/ncomms8286.

7.

Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies.

Nash CE, Mavria G, Baxter EW, Holliday DL, Tomlinson DC, Treanor D, Novitskaya V, Berditchevski F, Hanby AM, Speirs V.

Oncotarget. 2015 May 30;6(15):13731-41.

8.

Uses of the in vitro endothelial-fibroblast organotypic co-culture assay in angiogenesis research.

Hetheridge C, Mavria G, Mellor H.

Biochem Soc Trans. 2011 Dec;39(6):1597-600. doi: 10.1042/BST20110738. Review.

PMID:
22103493
9.

RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers.

Kaur S, Leszczynska K, Abraham S, Scarcia M, Hiltbrunner S, Marshall CJ, Mavria G, Bicknell R, Heath VL.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):657-64. doi: 10.1161/ATVBAHA.110.216341. Epub 2010 Dec 9.

PMID:
21148427
10.

Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.

D'Amico G, Robinson SD, Germain M, Reynolds LE, Thomas GJ, Elia G, Saunders G, Fruttiger M, Tybulewicz V, Mavria G, Hodivala-Dilke KM.

PLoS One. 2010 Mar 22;5(3):e9766. doi: 10.1371/journal.pone.0009766.

11.

VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation.

Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, Mavria G.

Curr Biol. 2009 Apr 28;19(8):668-74. doi: 10.1016/j.cub.2009.02.057. Epub 2009 Apr 2.

12.

ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis.

Mavria G, Vercoulen Y, Yeo M, Paterson H, Karasarides M, Marais R, Bird D, Marshall CJ.

Cancer Cell. 2006 Jan;9(1):33-44.

13.

RalGDS is required for tumor formation in a model of skin carcinogenesis.

González-García A, Pritchard CA, Paterson HF, Mavria G, Stamp G, Marshall CJ.

Cancer Cell. 2005 Mar;7(3):219-26.

14.

Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis.

Croft DR, Sahai E, Mavria G, Li S, Tsai J, Lee WM, Marshall CJ, Olson MF.

Cancer Res. 2004 Dec 15;64(24):8994-9001.

15.
16.

Variegated expression of CD8 alpha resulting from in situ deletion of regulatory sequences.

Garefalaki A, Coles M, Hirschberg S, Mavria G, Norton T, Hostert A, Kioussis D.

Immunity. 2002 May;16(5):635-47.

18.
19.

Hierarchical interactions of control elements determine CD8alpha gene expression in subsets of thymocytes and peripheral T cells.

Hostert A, Garefalaki A, Mavria G, Tolaini M, Roderick K, Norton T, Mee PJ, Tybulewicz VL, Coles M, Kioussis D.

Immunity. 1998 Oct;9(4):497-508.

20.

Transcriptional regulation of MHC class I gene expression in rat oligodendrocytes.

Mavria G, Hall KT, Jones RA, Blair GE.

Biochem J. 1998 Feb 15;330 ( Pt 1):155-61.

21.
22.

Effects of different antigenic microenvironments on the course of CD8+ T cell responses in vivo.

Tarazona R, Sponaas AM, Mavria G, Zhou M, Schulz R, Tomlinson P, Antoniou J, Mellor AL.

Int Immunol. 1996 Mar;8(3):351-8.

PMID:
8671621

Supplemental Content

Loading ...
Support Center